<DOC>
	<DOCNO>NCT02149342</DOCNO>
	<brief_summary>This pilot study compare two photosensitizers , hexylaminolaevulinate ( HAL ) methylaminolaevulinate ( MAL ) , treatment actinic keratoses . Study conduct use randomize split-face design . Efficacy assess clinically , histologically 3 12 month . Pain treatment adverse reaction one week record .</brief_summary>
	<brief_title>Daylight-mediated Photodynamic Therapy Actinic Keratoses : Comparing 0.2 % HAL With 16 % MAL</brief_title>
	<detailed_description>Study recruit 16-20 voluuntering patient symmetrical actinic damage face scalp . Treatment sit randomize receive either hexylaminolaevulinate 0.2 % methylaminolaevulinate ( 16 % MAL ) photosensitizers ( 0.25mm-thick layer ) . A web-based validated program ( Research Randomizer ) generate randomized list define treatment side . The randomization result keep blinded investigator conduct follow-up visit , pathologist , patient . Pre-treatment procedure include application sunscreen 15 minute curettage treatment area . Illumination perform use 2 hour daylight-exposure . Efficacy assess clinically , histologically 3 12 month blind observer . Pain treatment adverse reaction one week record .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Methyl 5-aminolevulinate</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>Symmetrical actinic damage face scalp Pregnancy Lactation Allergy photosensitizer Photodermatose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Actinic keratoses</keyword>
	<keyword>Daylight-PDT</keyword>
	<keyword>Hexylaminolaevulinate</keyword>
	<keyword>HAL</keyword>
	<keyword>Methylaminolaevulinate</keyword>
	<keyword>MAL</keyword>
	<keyword>Hyperspectral imaging</keyword>
</DOC>